Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Magdalena Budryk"'
Publikováno v:
Contemporary Oncology, Vol 20, Iss 5, Pp 381-384 (2016)
Aim of the study: The presence of BRCA germline mutations in patients with ovarian cancer has been shown to have predictive and prognostic significance, including increased platinum-sensitivity. The aim of the study was to evaluate if patients with B
Externí odkaz:
https://doaj.org/article/b04f2be4a75845c39efa1f25c570d84c
Autor:
Jolanta Pamuła Piłat, Ewa Grzybowska, Magdalena Budryk, Joanna Huszno, Zofia Kołosza, Elżbieta Nowara, Karolina Tecza
Publikováno v:
Oncology. 90:193-198
Objective: The suppressor gene CHEK2 encodes a cell cycle checkpoint kinase, involved in cell cycle regulation, apoptosis and response to DNA damage. The aim of this study was to analyze the differences between CHEK2 mutation carriers (CHEK2*1100delC
Publikováno v:
Contemporary Oncology
Aim of the study Treatment toxicity may decrease the treatment effectiveness due to the need to reduce the dose or increase the interval between cycles. The aim of this study was to distinguish the risk factors for treatment side effects in breast ca
Publikováno v:
Oncology. 85:278-282
Objective: The presence of BRCA gene mutation and low expressions of BRCA proteins are associated with a greater sensitivity of tumor cells to ionizing radiation and to cytostatics damaging the DNA of the cells. The purpose of this study was to estim
Autor:
Jan Lubinski, Rafal Wisniowski, Tomasz Mierzwa, Steven A. Narod, Rebecca Dent, Ewa Grzybowska, Małgorzata Stawicka, Magdalena Budryk, Tomasz Huzarski, Jacek Gronwald, Marek Szwiec, Monika Siołek, Tomasz Byrski
Publikováno v:
Journal of Clinical Oncology. 28:375-379
Purpose To estimate the rate of pathologic complete response (pCR) to neoadjuvant chemotherapy in BRCA1 mutation carriers according to chemotherapy regimen. Patients and Methods From a registry of 6,903 patients, we identified 102 women who carried a
Autor:
Joanna, Huszno, Magdalena, Budryk, Zofia, Kołosza, Karolina, Tęcza, Jolanta, Pamuła Piłat, Elżbieta, Nowara, Ewa, Grzybowska
Publikováno v:
Oncology. 90(4)
The suppressor gene CHEK2 encodes a cell cycle checkpoint kinase, involved in cell cycle regulation, apoptosis and response to DNA damage. The aim of this study was to analyze the differences between CHEK2 mutation carriers (CHEK2*1100delC/I157T) and
Autor:
Elżbieta Nowara, Beata Kaleta, Agnieszka Badora, Marlena Sikora-Jopek, Anna Smok-Ragankiewicz, Magdalena Budryk
Publikováno v:
Ginekologia polska. 84(10)
Mutations of BRCA1 and BRCA2 genes account for the majority of hereditary breast and ovarian cancers. So far, risk-reducing salpingo-oophorectomy has been the most effective strategy for gynecological cancer prevention in susceptibility gene mutation
Publikováno v:
Oncology. 85(5)
The presence of BRCA gene mutation and low expressions of BRCA proteins are associated with a greater sensitivity of tumor cells to ionizing radiation and to cytostatics damaging the DNA of the cells. The purpose of this study was to estimate the rat
Publikováno v:
Polish Journal of Surgery. 81
Autor:
Joanna Huszno, Karolina Tecza, Ewa A. Grzybowska, Elżbieta Nowara, J. Pamula Pilat, Zofia Kołosza, Magdalena Budryk
Publikováno v:
European Journal of Cancer. 51:S44